Dental Care Clinics in Foxboro, MA Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Joel Pearlman Dmd Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 113 Washington St, Foxboro, MA 02035 Phone: 508-543-7774 Fax: 508-543-7747 |
Foxboro Dental Associates Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Unit #103, Foxboro, MA 02035 Phone: 508-543-7901 Fax: 508-543-3147 |
Anita Karasko Dmd Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 26 Main St, Foxboro, MA 02035 Phone: 508-543-7755 Fax: 508-543-7788 |
News Archive
Suckling infants trigger surges of trust hormone in mothers' brains
Researchers from the University of Warwick, in collaboration with other universities and institutes in Edinburgh, France and Italy, have for the first time been able to show exactly how, when a baby suckles at a mother's breast, it starts a chain of events that leads to surges of the "trust" hormone oxytocin being released in their mothers brains.
Optimer reports grant of inducement stock options
Optimer Pharmaceuticals, Inc. announced today that on March 31, 2011 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 258,000 shares of common stock to 7 new employees.
Report shows identical genetic mutations are shared among neurodevelopmental disorders
A paper published this month in the prestigious medical journal The Lancet Neurology suggests that a broad spectrum of developmental and psychiatric disorders, ranging from autism and intellectual disability to schizophrenia, should be conceptualized as different manifestations of a common underlying denominator, "developmental brain dysfunction," rather than completely independent conditions with distinct causes.
Amgen outlines key recommendations for implementing approval pathway for biosimilars
Amgen Senior Vice President of Research and Development Joe Miletich, M.D., Ph.D., will urge members of a U.S. Food and Drug Administration (FDA) panel charged with implementing a pathway for biosimilars to establish approval standards that ensure patient safety and follow a science-based approach.
› Verified 1 days ago